Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever
- PMID: 26175069
- DOI: 10.1007/s00705-015-2519-7
Higher levels of dengue-virus-specific IgG and IgA during pre-defervescence associated with primary dengue hemorrhagic fever
Abstract
Dengue hemorrhagic fever (DHF), although predominantly associated with secondary infections, has also been reported in primary infections. An enhanced immune response including antibodies and cytokines is implicated in the pathogenesis of secondary DHF. However, the factors operating in primary DHF are poorly understood. To understand the role of the antibody response, the relative levels of different antibody isotypes during the acute phase of infection in primary and secondary dengue infections were determined. Levels of DENV-specific IgM, IgG, IgA and IgE were measured in the serum samples of 200 dengue patients and 20 dengue-naïve individuals. Samples were collected within 15 days of onset of illness. The DENV-specific IgM levels were significantly higher in DF cases compared to DHF, which was more evident in secondary infections and in post-defervescence samples. The levels of IgG, IgA and IgE were higher in DHF cases, with greater significance in primary infections. A higher level of IgG in DHF cases was evident in pre-defervescence samples, whilst the IgE level was higher in pre- and post-defervescence samples. There was a significant correlation of IgG titres with platelet counts, with higher titres associated with lower platelet counts. It is speculated that IgG, IgA and IgE produced in response to primary infections may contribute to pathogenesis, whilst IgM produced in response to secondary infections may protect against progression to severe disease.
Similar articles
-
Dynamics of interleukin-21 production during the clinical course of primary and secondary dengue virus infections.Immunol Lett. 2014 Sep;161(1):89-95. doi: 10.1016/j.imlet.2014.05.006. Epub 2014 May 22. Immunol Lett. 2014. PMID: 24858204
-
Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar.J Med Virol. 2013 Jul;85(7):1258-66. doi: 10.1002/jmv.23577. Epub 2013 Apr 17. J Med Virol. 2013. PMID: 23595687
-
Dengue specific immunoglobulins M, A, and E in primary and secondary dengue 4 infected Salvadorian children.J Med Virol. 2014 Sep;86(9):1576-83. doi: 10.1002/jmv.23833. Epub 2013 Nov 19. J Med Virol. 2014. PMID: 24615872
-
Progress towards understanding the pathogenesis of dengue hemorrhagic fever.Virol Sin. 2017 Feb;32(1):16-22. doi: 10.1007/s12250-016-3855-9. Epub 2016 Nov 14. Virol Sin. 2017. PMID: 27853992 Free PMC article. Review.
-
Dengue hemorrhagic fever - A systemic literature review of current perspectives on pathogenesis, prevention and control.J Microbiol Immunol Infect. 2020 Dec;53(6):963-978. doi: 10.1016/j.jmii.2020.03.007. Epub 2020 Mar 26. J Microbiol Immunol Infect. 2020. PMID: 32265181
Cited by
-
Development and Characterization of a Multiplex Assay to Quantify Complement-Fixing Antibodies against Dengue Virus.Int J Mol Sci. 2021 Nov 5;22(21):12004. doi: 10.3390/ijms222112004. Int J Mol Sci. 2021. PMID: 34769432 Free PMC article.
-
Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection.Front Immunol. 2021 Nov 24;12:777672. doi: 10.3389/fimmu.2021.777672. eCollection 2021. Front Immunol. 2021. PMID: 34899736 Free PMC article.
-
Shared IgG Infection Signatures vs. Hemorrhage-Restricted IgA Clusters in Human Dengue: A Phenotype of Differential Class-Switch via TGFβ1.Front Immunol. 2017 Dec 4;8:1726. doi: 10.3389/fimmu.2017.01726. eCollection 2017. Front Immunol. 2017. PMID: 29255469 Free PMC article.
-
Secretory phospholipase A2 in the pathogenesis of acute dengue infection.Immun Inflamm Dis. 2016 Dec 11;5(1):7-15. doi: 10.1002/iid3.135. eCollection 2017 Mar. Immun Inflamm Dis. 2016. PMID: 28250920 Free PMC article.
-
Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes.Vaccines (Basel). 2024 Aug 1;12(8):874. doi: 10.3390/vaccines12080874. Vaccines (Basel). 2024. PMID: 39204000 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous